Aridis Pharmaceuticals, Inc.
ARDSDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614067
Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Aridis Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 22 | 19 | −3 |
| Shares | 1.92M | 1.87M | −53.1K (−2.8%) |
| Value | $3.38M | $2.05M | −$1.33M (−39.3%) |
New holders (3)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 10,804 | $12.0K | 0.00% |
| B. Riley Wealth Management, Inc. | 10,000 | $11.0K | 0.00% |
| UBS Group AG | 8,293 | $9.00K | 0.00% |
Sold out (6)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Perritt Capital Management Inc | 24,000 | $42.0K |
| XTX Topco Ltd | 11,867 | $21.0K |
| Susquehanna International Group, LLP | 10,453 | $18.0K |
| Advisor Group Holdings, Inc. | 9,000 | $16.0K |
| Morgan Stanley | 1,275 | $2.00K |
| Focused Wealth Management, Inc | 100 | $0 |